Monro, Inc. carries a market capitalization of 498.42M, placing it among publicly traded companies globally. Its enterprise value stands at 952.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 498.42M |
| Enterprise Value | 952.65M |
Monro, Inc. currently has 30.02M shares outstanding.
| Shares Outstanding | 30.02M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Monro, Inc. trades at a trailing price-to-earnings ratio of 583.46. The price-to-sales ratio is 0.42, and the price-to-book ratio stands at 0.83.
| PE Ratio | 583.46 |
| PS Ratio | 0.42 |
| PB Ratio | 0.83 |
| P/TBV Ratio | -3.15 |
| P/FCF Ratio | 6.99 |
| P/OCF Ratio | 6.83 |
On an enterprise value basis, Monro, Inc. trades at an EV/EBITDA multiple of 11.66 and an EV/FCF ratio of 13.52. The EV/Sales ratio of 0.82 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 47.56 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.82 |
| EV / EBITDA | 11.66 |
| EV / EBIT | 47.56 |
| EV / FCF | 13.52 |
Monro, Inc. maintains a current ratio of 0.46, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.46 |
| Quick Ratio | 0.12 |
| Debt / Equity | 82.15 |
| Debt / EBITDA | 5.95 |
| Interest Coverage | N/A |
Monro, Inc. posts a return on equity of 0.14 and a return on invested capital of 1.26.
| Return on Equity (ROE) | 0.14 |
| Return on Assets (ROA) | 0.14 |
| Return on Invested Capital (ROIC) | 1.26 |
| Return on Capital Employed (ROCE) | 0.20 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.47 |
Over the trailing twelve months, Monro, Inc. has paid 927,000.00 in income taxes, reflecting an effective tax rate of 29.90.
| Income Tax | 927,000.00 |
| Effective Tax Rate | 29.90 |
Monro, Inc.'s stock has gained approximately 12.54237% over the past 52 weeks. The 50-day moving average sits at 16.43, while the 200-day moving average is 18.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | 12.54237% |
| 50-Day Moving Average | 16.43 |
| 200-Day Moving Average | 18.12 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Monro, Inc. generated 1.16B in revenue and converted that into 2.17M in net income, yielding earnings per share of 0.07. EBITDA reached 81.70M, while operating income came in at 20.03M.
| Revenue | 1.16B |
| Gross Profit | 405.26M |
| Operating Income | 20.03M |
| Pretax Income | 3.10M |
| Net Income | 2.17M |
| EBITDA | 81.70M |
| EBIT | 20.03M |
| Earnings Per Share (EPS) | 0.07 |
Monro, Inc. holds 14.63M in cash and equivalents against 485.90M in total debt, resulting in a net debt position of 45.37M. Total book value stands at 582.06M, with working capital of -281.20M providing operational flexibility.
| Cash & Cash Equivalents | 14.63M |
| Total Debt | 485.90M |
| Net Debt | 45.37M |
| Equity (Book Value) | 582.06M |
| Book Value Per Share | 19.40 |
| Working Capital | -281.20M |
Monro, Inc. produced 70.44M in operating cash flow over the past twelve months.
| Operating Cash Flow | 70.44M |
| Capital Expenditures | N/A |
| Free Cash Flow | 70.44M |
| FCF Per Share | 2.35 |
Monro, Inc. operates with a gross margin of 35.02, reflecting its pricing power and cost economics. The operating margin of 1.73 and net profit margin of 0.19 provide insight into operational efficiency.
| Gross Margin | 35.02 |
| Operating Margin | 1.73 |
| Pretax Margin | 0.27 |
| Profit Margin | 0.19 |
| EBITDA Margin | 7.06 |
The company's payout ratio of 4,073.58 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.16 |
| Dividend Yield | N/A |
| Payout Ratio | 4,073.58 |
| Shareholder Yield | 15.66 |
| FCF Yield | 14.31 |
Monro, Inc.'s most recent stock split took place on December 27, 2010 with a 2:3 split ratio.
| Last Split Date | 12/27/2010 |
| Split Ratio | 2:3 |
Monro, Inc. posts an Altman Z-Score of 2.36, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.36 |